While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a v ...

JHVEPhoto/iStock Editorial via Getty Images McKesson (NYSE:MCK) published their Q3 FY24 earnings on February 7th, reporting 15% topline growth and 12.2% adjusted EPS growth. I highlighted their growth opportunities in GLP-1 medications and their significant share buyback program in my introductory coverage. I maintain a 'Strong Buy' rating with a fair value of $660 per share. Strong GLP-1 Growth and Prior Authorization Network In Q3 FY24, McKesson delivered 15% revenue growth on a constant currency basi ...

McKesson Corporation (MCK) reported third-quarter fiscal 2024 adjusted earnings per share (EPS) of $7.74, which beat the Zacks Consensus Estimate of $7.05 by 9.8%. The bottom line also improved 12% on a year-over-year basis.GAAP EPS was $4.42, down 42% from the year-ago quarter’s level. The significant decline was due to the provision of bad debts worth $515 million for uncollected trade accounts receivable related to the bankruptcy of Rite Aid Corporation. Moreover, the company recorded a pre-tax benefit o ...

McKesson Corporation Third Quarter Fiscal 2024 Earnings Call Cautionary Statements Cautionary Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward- looking statements may be identified by their use of terminology such as “believes,” “expects,” “anticipates,” “may,” “will,”“should,” “seeks,” “approximately,” “intends,” “projects,” “plans,” “estimates,” “targets,” or the ...

McKesson Corporation. (NYSE:MCK) Q3 2024 Earnings Conference Call February 7, 2024 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Eric Percher - Nephron Research Lisa Gill - JPMorgan Allen Lutz - Bank of America Brian Tanquilut - Jefferies Kevin Caliendo - UBS Eric Coldwell - Baird Stephanie Davis - Barclays Erin Wright - Morgan Stanley Daniel Gros ...

McKesson (MCK) reported $80.9 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 14.8%. EPS of $7.74 for the same period compares to $6.90 a year ago.The reported revenue represents a surprise of +4.41% over the Zacks Consensus Estimate of $77.48 billion. With the consensus EPS estimate being $7.05, the EPS surprise was +9.79%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 7th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-13252 McKESSON CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3207296 (State or other jurisdiction (I.R.S ...

Shares of McKesson (MCK) have been strong performers lately, with the stock up 5.5% over the past month. The stock hit a new 52-week high of $508.09 in the previous session. McKesson has gained 9% since the start of the year compared to the 3.6% move for the Zacks Medical sector and the 1.8% return for the Zacks Medical - Dental Supplies industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the l ...

In its upcoming report, McKesson (MCK) is predicted by Wall Street analysts to post quarterly earnings of $7.05 per share, reflecting an increase of 2.2% compared to the same period last year. Revenues are forecasted to be $77.48 billion, representing a year-over-year increase of 9.9%.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Bef ...